Abstract | OBJECTIVE: METHODS: RESULTS: CONCLUSIONS:
Polyamide suppressed the stiffness, ECM formation, and thickening of the injured peritoneum that occurs during EPS pathogenesis. These data suggest that PI polyamide targeted to the TGF-β1 promoter will be a specific and feasible therapeutic strategy for patients with EPS.
|
Authors | Kazuo Serie, Noboru Fukuda, Shigeki Nakai, Hiroyuki Matsuda, Takashi Maruyama, Yoshinobu Murayama, Sadao Omata |
Journal | Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
(Perit Dial Int)
2012 Jul-Aug
Vol. 32
Issue 4
Pg. 462-72
ISSN: 1718-4304 [Electronic] United States |
PMID | 22215658
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Imidazoles
- Nylons
- Pyrroles
- RNA, Messenger
- Tgfb1 protein, rat
- Transforming Growth Factor beta1
- Vascular Endothelial Growth Factor A
|
Topics |
- Animals
- Cells, Cultured
- Electrophoretic Mobility Shift Assay
- Extracellular Matrix
- Gene Silencing
- Imidazoles
(pharmacology, therapeutic use)
- Male
- Nylons
(pharmacology)
- Peritoneal Dialysis
(adverse effects)
- Peritoneal Fibrosis
(genetics, metabolism)
- Peritoneum
(drug effects, metabolism)
- Pyrroles
(pharmacology, therapeutic use)
- RNA, Messenger
(biosynthesis)
- Rats
- Rats, Sprague-Dawley
- Rats, Wistar
- Transforming Growth Factor beta1
(genetics, metabolism)
- Vascular Endothelial Growth Factor A
(genetics, metabolism)
|